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Fractional direct dialysis quantification: A new approach for prescrip-
tion and monitoring hemodialysis therapy. We describe a new method-
ology, fractional direct dialysis quantification (FDDQ) utilizing the Fresin-
ius® Dialysate Sampling Module (DSM), for quantitating total solute
removal during hemodialysis (HD). Our data demonstrate that this
technique and Direct Dialysis Quantification (DDQ) yield virtually iden-
tical results. FDDQ, however, obviates the practical obstacles that have
limited the applicability of DDQ. We discuss the theoretical and practical
advantages of this methodology, as compared to urea kinetic modeling
(UKM) with Kt/V, for prescribing and monitoring dialysis therapy. FDDQ
provides reliable and accurate quantitative data of dialysis function and
protein catabolic rate (PCR) independent of questionable theoretical
assumptions and parameters required for UKM with KtIV. It is simple to
comprehend and apply. It permits easy comparison of standard and rapid
high efficiency dialyses. It also facilitates the quantitative comparison of
HD and continuous therapies (peritoneal dialysis and various types of
continuous hemofiltration). FDDQ permits the use of other solutes, in
place of or in addition to urea, for the quantitation of HD. Because of its
simplicity and probable low cost, it can be used with each HD session. It
will thus provide accurate data on delivered versus prescribed therapy.
These features should permit more accurate monitoring and lead to a
clearer understanding of the relationship of outcomes versus delivered
dialysis dose, and consequently more effective adjustment of dialysis
therapy.
Following the introduction of chronic maintenance hemodialy-
sis (HD) as a viable therapeutic modality, its adequacy was
assessed primarily in a retrospective qualitative manner on the
basis of clinical or laboratory outcomes in individual patients.
Subsequent experience and publication of the National Cooper-
ative Dialysis Study (NCDS) results [1] suggested the need for
prospective quantitative assessment methodologies. The develop-
ment and acceptance of these quantitative methodologies for the
prescription and monitoring of dialysis therapy have revolution-
ized chronic maintenance HD.
Urea kinetic modeling (UKM) [21 utilizing the KtIV parameter
[3, 41 and direct total dialysate quantification (DDQ) [5—8] are the
primary methodologies currently available for the quantitative
measurement of dialysis adequacy. Both suffer from serious
shortcomings. DDQ, total dialysis effluent collection and mea-
surement of its solute content, is the most direct, tangible and
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reliable method of dialysis quantification, and has been termed
the "gold standard." The procedure is, however, too cumbersome
for routine clinical use [8]. UKM utilizing the Kt/V parameter is
less cumbersome but conceptually more complex. It is dependent
on a questionable and/or controversial hypothesis, does not
readily permit comparison of different dialytic techniques, and is
not easily adaptable to kinetic modeling of other retained solutes
[8—101.
We report a technique, fractional dialysis quantification
(FDDQ), and equipment, the Fresinius® Dialysate Sampling
Module (DSM), for the quantitative assessment of HD. It has all
the advantages of other currently available techniques without
their drawbacks, and affords potential benefits unattainable with
other methodologies.
Methods
To compare and validate FDDQ against the DDQ standard we
simultaneously performed both procedures on 35 treatments in
ten HD patients. All were on HD three times per week, with a
variety of dialyzers, treatment times and blood flow rates. Dialy-
sate flow rate was kept constant at 800 cc/mm. Most studies were
performed on two consecutive weeks on the first two HD of the
week.
DDQ
A 200 liter capacity drum was modified for the study. A clear
plastic tube was inserted into the base, mounted externally and
calibrated at one liter drum volume intervals. The drum was
mounted on an digital electronic scale. Therefore, the collected
total dialysis effluent volume (spent dialysate plus ultrafiltrate;
TE) could be determined visually or by weight. A drainage valve
in the bottom of the drum permitted complete drainage of dialysis
effluent or rinse fluid between procedures. A sample valve in the
midportion of the drum was used for dialysis effluent sampling. An
opening in the top permitted the insertion of a motor (electric
hand drill)-driven mixing rod with an impeller at the bottom and
midportion of the drum. Following and preceding each study the
drum was rinsed thoroughly. The electronic scale was calibrated
and zeroed, following which HD treatment and dialysis effluent
collection were initiated. At the end of the HD session the TE
volume was recorded and agitation begun with the mixing rod.
Effluent samples were drawn for analysis of urea nitrogen (UN)
and creatinine (Cr) during continued agitation following a mini-
mum of five minutes of mixing.
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Dialysate sampling module (DSM)
FDDQ
The essence of this technique was the collection of a small,
precisely defined and reproducible fraction of TE, such that the
solute concentrations in TE and in the fractional sample were
identical. This was accomplished by continuous online fractional
sampling of dialysis effluent via the DSM. The DSM (Fig. 1) was
electrically and electronically connected to the dialysis machine
via a ribbon connector. A 'T' connection from the dialysate
effluent drain line to the DSM permitted the latter to remove a
predetermined volume of effluent (5 to 20 mI/mm) into a 3 liter
peritoneal dialysate collection (sample) bag. Utilizing this version
of the DSM, the sampling rate was set at 5 ml/min. (A newer
version of the DSM samples a specific percentage of dialysis
effluent and automatically ceases sampling whenever there is an
interruption of dialysate or blood flow, further simplifying the
procedure and calculations, and increasing accuracy of the tech-
nique). To allow for dead space in the system, the first 500 ml of
dialysate following initiation of blood flow was not sampled by the
DSM. For the same reason 500 cc of effluent following termina-
tion of blood flow was sampled. The sample volume was most
accurately measured by weighing the bag on the Digiflow
electronic scale. After the bag was kneaded or rolled to assure
complete mixing, samples were drawn for analysis of urea and
creatinine concentrations. The formulas for calculating total
dialysis effluent volume and total solute content are in Appendix
Table 1. DDQ versus FDDQ dialysate effluent volumes and solute
concentrations
DDQ
FDDQ
sample
FDDQ
calculated P
Dialysate
effluent liter 156.6 12.17 0.935 0.006 149.56 10.72 NS
UN mg/c/I 10.09 3.96 10.31 4.17 — NS
Total UN
removed g 16.03 7.18 — 15.93 7.09 NS
Creatinine mg/dl 1.17 0.38 1.19 0.42 — NS
Total creatinine 1.86 0.74 — 1.85 0.76 NS
removed g
r = 0.97
I is not significant.
DDQ vs. FDDQ
A. P values for the results were analyzed
method.
Results
by the Student's t-test
The FDDQ sample volume was a manageable 935 ml. The
volumes of dialysis effluent collected by DDQ, 156.6 12.17
liters, and calculated by FDDQ, 149.56 10.72 liters, are
statistically similar (Table 1). This statistically insignificant differ-
ence is due to the experimental design wherein the pre- and
post-rinse and dead space dialysate were drained into the DDQ
Sample rate set point switch
Fig. 1. Dialysate sampling module (DSM).
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collection drum but bypassed the DSM. This explains the slightly
greater TE volumes and the minimally lower solute concentra-
tions (see below) in DDQ as compared to FDDQ. The above,
however, would not affect the total solute content.
UN and creatinine concentrations in the total DDQ collection
(10.09 3.96 mg/dl and 1.17 0.38 mgldl) and in the FDDQ
sample (10.31 4.17 mg/dl and 1.19 0.42 mg/dl) were statisti-
cally similar (Table 1). The minimally lower DDQ concentrations
are explained above. Total UN and total creatinine removed, as
measured by DDQ (16.03 7.18 g and 1.86 0.74 g) and
calculated by FDDQ (15.93 7.09 g and 1.85 0.76 g) were
statistically equivalent (Table I and Figs. 2 and 3).
Discussion
The goal of dialysis therapy (DT) is to maximize the elimination
of various solutes so that physiologically necessary solute (or
precursor) ingestion or production can continue uncompromised
while serum concentrations are maintained at tolerable levels.
However the maximum deliverable DT is often limited by tech-
nical, clinical or practical factors (such as patient acceptance and
cost). Hence, patients receiving DT usually also require a reduc-
tion of solute intake. The clinician thus faces a dual challenge. DT
needs to be maximized to permit adequate solute ingestion, but it
cannot exceed realistic constraints. Solute ingestion should not
exceed its rate of removal by DT but it must not drop below
physiologic requirements. To achieve these goals the clinician
needs the ability to reliably measure solute intake and dialytic
solute elimination.
Urea is the most commonly used surrogate for the as yet
unidentified uremic toxins, the blood urea nitrogen (BUN), the
marker for blood uremic toxin concentration and urinary and
dialysate urea nitrogen (UN), the surrogate for uremic toxin
turnover (ingestion and elimination). In the steady state, UN is
derived mostly from the catabolism of ingested proteins. There-
fore, one of the therapeutic approaches in ESRD is limitation of
protein intake and/or the prescription of ketoacid analogues of
essential amino acids that may permit recycling of UN [11]. This
therapeutic approach is limited by recent data that establish
protein malnutrition as a major cause of morbidity and mortality
in ESRD [12, 131. Ideally we should prescribe and deliver a
maximal amount of dialysis that is well in excess of that required
to handle the byproducts of ingested protein. However, the
dialytic UN removal is limited by a variety technical limitations,
clinical issues and practical considerations [11, 13]. In the treat-
ment of ESRD the clinician has to ensure an adequate protein
intake and a dose of DT that exceeds the minimum required to
eliminate protein byproducts. To achieve and maintain this bal-
ance it is necessary to have a measure of protein intake and
dialytic (and residual renal) UN removal.
DDQ is the most direct and accurate method for measuring
dialytic UN removal [5—8]. In the steady state, the UN elimination
rate directly reflects its appearance rate which is related to the
PCR, which in the non-catabolic patient is primarily a function of
dietary protein intake [4, 14]. By using a formula that accounts for
non-UN protein losses and the small fraction of protein nitrogen
products excreted via the gut, it is possible to calculate the PCR
[4, 15—17] and therefore total protein intake from total dialysate
(plus urinary) UN content. Therefore, through a single measure-
ment of TE UN, the DDQ provides the most accurate measure of
two critical parameters of ESRD therapy, protein intake as
reflected by the PCR and the efficacy of the dialytic process, the
UN removal. The latter parameter is reported in the most
meaningful and clinically useful units, that is, the actual amount of
solute, UN, removed during a dialysis treatment and/or during a
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Fig. 3. Total creatinine removed (grams), DDQ versus FDDQ (r = 0.97).
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Fig. 2. Total urea nitrogen removed (grams), DDQ versus FDDQ (r = 0.99).
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specific time period. DDQ utilizing the latter value can also be
used to calculate KtIV most accurately (see below) [181.
Collecting, mixing and sampling total spent dialysate is too
cumbersome a procedure for routine clinical use. This practical
limitation of the standard DDQ methodology led to the concept
of UKM via the Kt/V parameter in an attempt to provide an easy
to use tool for monitoring and prescribing dialysis therapy.
Compared to DDQ, UKM has many drawbacks and limitations
and one major historic advantage.
UKM utilizes a variety of formulas to derive the PCR and Kt/V
from just two (or 3) BUN determinations, the ultrafiltration
volume, an assumed weight parameter and an assigned dialyzer
clearance (Kd) [8, 101. These formulas are based on hypothetical
concepts of questionable validity. Controversy exists regarding the
urea volume of distribution, the single pool kinetics model of urea
equilibration, the appropriate weight parameter (ideal vs. lean) [8,
10, 17], and the appropriate timing of the post-dialysis blood
sample (of particular concern in rapid high flux/high efficiency
HD) [18, 19]. Moreover, these formulas often yield implausible
values of 40 to 70% for the urea volume of distribution (V) [8, 17].
Substantial variations in V in individual patients over a short time
course have also been reported [81. Such an extreme and broad
range of values cast doubt on the clinical validity and usefulness of
the methodology.
Kd, dialyzer clearance (K in Kt/V), used in UKM calculations is
based on a manufacturer's in vitro or clinically determined in vivo
value. Actual K during any treatment or Kt/V determination may
be different from the assigned value, leading to spurious values for
PCR and Kt/V. Kd values may vary by dialyzer lot. Kd is also
affected by blood flow, dialysate flow and recirculation [8, 10, 17].
These factors may lead to substantial discrepancies between
prescribed and delivered Kt/V and desired and actual PCR.
Problems related to incomplete equilibration between extracel-
lular and intracellular urea during and immediately after rapid
high efficiency dialysis [18, 19] make it difficult to compare Kt/V
results from this form of HD with those obtained during standard
HD. Similarly, there is continued controversy regarding the use of
Kt/V to compare the efficacy of intermittent HD with continuous
peritoneal dialysis therapies [20]. These difficulties are related to
the fact that Kt/V is a dimensionless number and an abstract
concept rather than a tangible easily understood value, such as
"grams of UN removed per treatment." During HD the BUN
concentration and, therefore, the diffusion gradient and dialy-
sance vary throughout the procedure. Hence, HD Kt/V, as
calculated by UKM methodologies, represents a theoretical ca-
pacity rather than an actual achieved value. The situation is quite
different in continuous therapies such as PD with their relatively
steady-state serum solute concentrations. In the latter situation, as
in DDQ and FDDQ (see below), the values obtained, that is,
solute removed, solute clearance, or body volumes cleared of a
given solute, represent actual achieved results [21].
UKM with the Kt/V parameter does have a major historical
advantage. It was utilized in the NCDS [1—3], the best available
and most often cited study of guidelines for HD adequacy. As
such they are well known, if poorly understood, terms in the
dialysis community.
However, careful analysis of the NCDS results and subsequent
experience suggests that the important goals and independent
variables, in the treatment of ESRD are the PCR and BUN [9,
17]. Kt/V, a parameter of dialysis therapy adequate to achieve the
above end points, is therefore a dependent variable. It is thus
possible and even desirable to substitute, for Kt/V, a simpler,
more easily measured and more accurate parameter of dialysis
adequacy, such as the total UN removed during a dialysis session
or during a defined period of time.
Logic dictates that adequate dialysis must remove an amount of
UN that will permit the continued ingestion of the desired
quantity of protein (PCR) while maintaining the BUN at or below
a set level. FDDQ utilizing the DSM provides a simple and easy
technique for measuring that parameter, that is, total dialysate
UN, and through that for monitoring PCR and dialysis adequacy.
FDDQ and the DSM overcome the limitations of DDQ while
retaining all of its advantages. FDDQ is simpler and easier to
apply than UKM without the latter's theoretical pitfalls.
FDDQ provides a direct and accurate value for UN removed
during a dialysis treatment. As discussed for DDQ, this value can
be used to calculate the PCR and therefore the dietary protein
intake (DPI) by simple, empirical formulas. The total UN re-
moved and the calculated PCR are real and actual values. The
results are not dependent on assumptions about double versus
single pool kinetics, changing intra- and post-dialysis serum
concentration, volumes of distribution, choices of body wt param-
eters, nor even Kd. Nor is the validity of results influenced by
variations in blood or dialysate flow, recirculation or variations in
individual dialyzer performance (different lots, reuse). The data
represent actual delivered rather than theoretical 'expected' therapy.
The procedure is extremely simple to perform, does not require
complex calculations, does not require repetitive blood drawing
and requires only one dialysate UN determination. It should
therefore be relatively inexpensive. Compared to the recently
reported methodology of online monitoring of dialysate urea [22—
25], FDDQ requires less complex and less costly equipment, less
complex calculations, no extrapolations, and only one (vs. multiple)
UN determination. FDDQ may therefore be less costly and will
produce more accurate and unequivocal dialysis parameters.
In contrast to the Kt/V concept, the 'total UN removed'
parameter is conceptually simpler for physicians and dialysis
professionals to comprehend and apply. It is therefore more likely
to be applied correctly and frequently. Because of its simplicity
and low per procedure cost FDDQ could be performed during
every treatment, or at any desired frequency, providing absolute
data on delivered versus prescribed therapy. The reliable and
concrete PCR value it provides will permit careful and accurate
monitoring of patients' protein intake.
Because it is independent of urea equilibration in body com-
partments and of post-dialysis blood sampling, FDDQ, like DDQ
[18], permits easy comparison of dialysis adequacy between
standard and rapid high efficiency treatments.
The difficulties of comparing the dose and adequacy of inter-
mittent HD versus continuous dialysis therapies by the UKM
methodology, are largely obviated by FDDQ. Large discrepancies
in weekly Kt/V for HD versus PD have plagued researchers trying
to compare the adequacy and therapeutic effectiveness of the two
modalities [20]. PD adequacy evaluations are based on measure-
ment of total solute removed during a defined period. Similarly,
DDQ and FDDQ measure actual total solute removed during a
HD treatment. This permits a more reliable comparison of HD
and PD adequacy [21] and may explain the, until now, puzzling
similarity of outcomes with the two therapies [20, 21]. For
analogous reasons FDDQ will permit valid comparisons of dial-
ysis dose delivered by intermittent HD and continuous filtration
therapies.
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removal. Analysis of the total dialysate content of additional
solutes (creatinine, phosphate, B microglobulin, etc.) will permit
adjustment of therapy to maximize their removal and the benefits
of the dialysis process. Monitoring frequent dialysis sessions by
FDDQ will permit detection of, and compensation for delivered
therapy or protein intake that falls below prescribed levels.
Reprint requests to Chaim Chaiytan, M.D., Division of Nephrology &
Hypertension, The New York Hospital Medical Center of Queens, 56-45 Main
Street, Flushing, New York 11355, USA.
Appendix
Total dialysate volume and total dialysate solute by FDDQ
Abbreviations are: DF, dialysate flow rate (cc/mm); SF, FDDQ
sample collection rate (cc/mm); TE, total dialysis effluent volume;
TD, total dialysate volume (cc); SV, FDDQ total sample volume
(cc); UF, ultrafiltration volume; T, dialysis treatment time (mm).
To calculate the total dialysate volume by FDDQ:
(1) Since there is a constant proportion between dialysate and
sample flow rates,
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Finally, FDDQ lends itself to the use of solutes other than urea,
such as creatinine or, when identified, more specific uremic toxins,
for quantification of dialysis therapy. To apply KM via the Kt/V
concept to other solutes would require the identification for each
and every solute, its volume(s) of distribution, equilibration
kinetics and timing of blood samples, as well as the desired serum
concentration and the amount to be removed by the dialysis
procedure. FDDQ requires only the latter two parameters and is
thus readily applicable to the use of recognized salutes (creati-
nine, B microglobulin) and yet to be identified uremic toxins for
quantitative prescription and monitoring of dialysis therapy.
Future and prospective studies will define the appropriate
parameters and the most efficient utilization of this technique.
Pending such studies FDDQ can be utilized effectively by extrap-
olation from the NCDS and multiple additional reports [4, 9—13],
which define the desirable target BUN and DPI (or PCR) for the
dialysis population. Back calculation and adjustment for residual
renal function will yield the required steady-state dialytic UN
TD/SV = (DF x fl/(SF x I')
(2) Transposing and canceling T,
TD = (DFX SV)/SF
(3) Total dialysis effluent includes ultrafiltrate, thus
TE TD + UF = [(DF x SV)/SF] + UF
With the newer versions of the DSM, which samples a set
fraction of total dialysis effluent, the equation becomes even
simpler:
TE = [SV x 1/sampling fraction]
Total solute by FFDQ
Since the FDDQ sample collection is a constant fraction of total
dialysate drainage, the solute concentration in total dialysate
collected and in the sample are identical. Therefore,
Total solute = Sample solute concentration X TE
